Advertisement
Screener

Alkermes plc. (ALKS) Cash Flow Breakdown

2.8 / 5 stars · 68/120 Roast Me

Alkermes plc. Cash Flow Breakdown

Cash flow breakdown shows where Alkermes plc.'s cash came from and where it went: from running the business, from investing (buying or selling equipment, companies and investments) and from financing (borrowing, paying back loans, buying back shares, paying dividends). One row per year or quarter. A minus sign means cash went out. Financing is shown line by line: buybacks, dividends, debt paid back, new debt and the rest. All amounts are the filed figures for that period.

  • Fiscal year ended 2026-03-31: from running the business, $256.20M came in.
  • Fiscal year ended 2026-03-31: from investing, $1.79B went out.
  • Fiscal year ended 2026-03-31: from financing, $1.49B came in.

A minus sign means cash went out. * = worked out from the filed year-to-date figures (hover to see how); greyed = already counted inside another line.

Each year (12 month)

Fiscal year endRunning the businessFrom investingBuybacksDebt paid backNew debtStaff share taxNew shares soldOtherNot split outChange in cash
2026-03-31$256.20M*-$1.79B*-$25.69M*$1.51B*
2025-12-31$520.75M$295.50M-$31.03M$43.41M*$828.63M
2025-03-31$516.83M*-$62.26M*-$30.07M*-$445.45M*
2024-12-31$439.12M-$111.31M-$200.28M-$2.25M-$29.64M-$261.97M*-$166.32M
2024-03-31$443.76M*-$59.44M*-$3.00M*-$32.08M*-$249.89M*
2023-12-31$401.35M$53.36M-$3.00M-$28.47M-$258.24M*$165.00M
2023-03-31-$21.94M*$68.95M*-$3.00M*-$25.88M*$20.71M*
2022-12-31$21.04M-$64.54M-$3.00M-$18.20M$19.63M*-$45.07M
2022-03-31$168.54M*-$89.11M*-$23.23M*$21.33M*
2021-12-31$101.72M-$66.20M-$3.24M*$23.57M-$16.57M$25.32M*$64.58M
2021-03-31$77.97M*-$66.70M*-$10.83M*$28.53M*
2020-12-31$82.84M-$11.48M-$2.84M-$7.70M$8.37M*$69.19M
2020-03-31$9.59M*-$59.64M*-$2.84M*-$7.72M*$11.44M*
2019-12-31$72.08M-$141.83M-$2.84M-$9.32M$18.93M*-$62.99M
2019-03-31$148.33M*-$112.24M*-$12.78M*$15.42M*
2018-12-31$99.28M-$22.20M-$743.00K-$19.62M$18.75M*$75.47M
2018-03-31$6.10M*-$8.47M*-$19.01M*$26.58M*$5.20M*
2017-12-31$19.19M-$18.36M-$16.43M$20.52M*$4.92M
2017-03-31-$20.34M*$70.01M*-$2.49M*-$23.32M*-$42.53M*-$18.67M*
2016-12-31-$63.80M$127.24M-$69.24M*-$13.47M$4.23M$20.31M*$5.27M
2016-03-31-$99.65M*$58.00M*-$6.75M*-$24.51M*$28.71M*$34.87M*-$9.34M*
2015-12-31-$40.36M-$43.49M-$6.75M-$25.90M$28.58M$44.97M*-$42.95M
2015-03-31$16.69M*-$19.51M*-$6.75M*$29.95M*$32.61M*
2014-12-31$11.14M-$263.40M-$6.75M-$12.84M$248.41M$32.37M$47.58M*$56.50M
2014-03-31$88.75M*-$338.04M*-$6.75M*$18.56M*$296.85M*
2013-12-31$147.53M-$177.19M-$6.75M*-$11.67M*$15.91M*$63.85M*
2013-03-31$126.55M-$68.15M-$449.94M$366.48M-$4.81M$8.87M$34.36M*
2012-12-31$86.53M*$22.10M*-$4.96M*$5.56M*-$58.67M*
2012-03-31-$2.48M-$417.16M-$775.00K$444.10M-$3.68M$4.33M$20.86M*$45.21M
2011-03-31-$5.91M$5.63M-$1.41M-$39.24M*-$40.93M
2010-03-31-$12.25M$28.01M-$2.68M$246.00K-$20.89M*-$7.57M

Each quarter (3 month)

Quarter endRunning the businessFrom investingBuybacksDebt paid backNew debtStaff share taxNew shares soldOtherNot split outChange in cash
2026-06-30$145.18M*-$2.41M*$0.00*$0.00*-$1.10M*$18.30M*
2026-03-31-$165.74M-$2.08B-$27.70M$1.51B-$23.44M$14.10M*-$768.23M
2025-12-31$170.07M*$322.35M*-$266.00K*$11.18M*
2025-09-30$101.67M*-$6.74M*-$307.00K*
2025-06-30$150.20M*-$29.21M*-$1.68M*
2025-03-31$98.81M$9.10M-$28.78M$29.53M*$108.66M
2024-12-31$190.40M*-$13.88M*-$1.00K*$0.00*-$344.00K*-$281.32M*
2024-09-30$81.59M*-$109.33M*-$115.59M*-$750.00K*-$293.00K*$5.52M*
2024-06-30$146.03M*$51.85M*-$750.00K*-$651.00K*-$82.08M*
2024-03-31$21.11M-$39.95M-$750.00K-$28.35M$11.23M*-$36.72M
2023-12-31$107.24M*-$20.98M*-$750.00K*-$2.39M*-$273.35M*
2023-09-30$99.71M*-$119.36M*-$750.00K*-$796.00K*$3.11M*
2023-06-30$215.71M*$120.85M*-$750.00K*-$540.00K*$9.13M*
2023-03-31-$21.30M$72.85M-$750.00K-$24.74M$2.87M*$28.93M
2022-12-31$1.05M*$27.74M*-$750.00K*-$301.00K*
2022-09-30$625.00K*$8.90M*-$750.00K*-$320.00K*
2022-06-30-$2.31M*-$40.54M*-$750.00K*-$514.00K*$16.20M*
2022-03-31$21.68M-$60.64M-$750.00K-$17.07M$1.79M*-$54.99M
2021-12-31$31.02M*-$742.00K*-$750.00K$0.00*-$2.94M*
2021-09-30$82.78M*-$31.71M*-$766.00K*$0.00*-$2.51M*$4.31M*
2021-06-30$33.06M*$3.98M*-$715.00K*$0.00*-$707.00K*$17.70M*
2021-03-31-$45.15M-$37.73M-$262.00K$23.57M-$10.41M$2.05M*-$67.93M
2020-12-31$67.34M*-$35.10M*-$711.00K*-$94.00K*
2020-09-30$60.20M*-$8.23M*-$711.00K*-$201.00K*
2020-06-30-$4.43M*$14.35M*-$710.00K*-$123.00K*$3.85M*
2020-03-31-$40.27M$17.49M-$711.00K-$7.28M$3.07M*-$27.70M
2019-12-31$42.07M*-$101.47M*-$711.00K*-$87.00K*$2.54M*
2019-09-30$30.97M*$31.59M*-$711.00K*-$156.00K*$3.77M*
2019-06-30-$23.18M*-$7.25M*-$710.00K*-$194.00K*$2.05M*
2019-03-31$22.21M-$64.70M-$711.00K-$8.88M$10.55M*-$41.53M
2018-12-31$60.51M*-$7.80M*$678.00K*-$3.84M*$1.17M*
2018-09-30$33.48M*$26.15M*-$711.00K*-$43.00K*$1.32M*
2018-06-30$32.13M*-$65.88M*-$18.00K*$3.12M*
2018-03-31-$26.84M$25.34M-$15.72M$12.43M*-$4.79M
2017-12-31$35.91M*-$14.19M*-$750.00K*-$15.00K*$5.22M*$26.17M*
2017-09-30$19.48M*-$13.61M*-$750.00K*-$1.00K*$1.89M*$7.02M*
2017-06-30-$22.45M*-$6.02M*-$750.00K*-$3.27M*$9.29M*-$23.20M*
2017-03-31-$13.75M$15.46M-$750.00K-$13.15M$7.11M*-$5.07M
2016-12-31$7.56M*-$20.88M*$61.63M*-$5.04M*-$889.00K*-$58.25M*-$15.86M*
2016-09-30$14.73M*$46.99M*-$61.69M*$0.00*$512.00K*$5.26M*$5.80M*
2016-06-30-$28.88M*$28.44M*-$1.69M*-$5.13M*-$268.00K*$3.99M*-$3.54M*
2016-03-31-$57.21M$72.69M-$1.69M-$3.30M*$4.87M$18.87M
2015-12-31$2.42M*-$42.22M*-$1.69M*-$8.84M*-$4.24M*$13.34M*-$41.23M*
2015-09-30-$29.45M*$30.51M*-$1.69M*-$33.00K*$16.31M*$9.80M*$25.45M*
2015-06-30-$15.41M*-$2.99M*-$1.69M*-$12.34M*$11.76M*$8.24M*-$12.42M*
2015-03-31$2.08M-$28.79M-$1.69M-$4.69M$4.74M$13.60M*-$14.75M
2014-12-31$13.64M*$46.13M*-$1.69M*-$274.00K*$0.00*$9.92M*$20.15M*$87.88M*
2014-09-30-$7.81M*-$63.69M*-$1.69M*-$20.00K*$0.00*$15.46M*$5.61M*-$52.14M*
2014-06-30$8.78M*$26.84M*-$1.69M*$0.00*-$179.00K*-$1.75M*
2014-03-31-$3.47M-$272.67M-$1.69M$248.41M$7.16M$11.03M*
2013-12-31$38.11M*-$57.30M*-$1.69M*-$3.14M*$2.94M*$15.13M*
2013-09-30$41.37M*-$2.67M*-$1.69M*-$6.00K*$1.24M*$18.86M*
2013-06-30$12.75M-$5.40M-$1.69M-$8.52M$7.22M$15.08M*
2013-03-31$55.30M-$111.83M-$1.69M-$2.07M-$5.00K$4.51M$16.85M*
2012-12-31$26.20M*-$31.30M*-$1.69M*$0.00*-$1.48M*$3.97M*$7.78M*
2012-09-30$49.75M*$65.64M*-$445.79M*$0.00*$282.00K*$376.95M*
2012-06-30-$4.70M$9.35M-$775.00K-$3.32M$105.00K$1.34M*
2012-03-31$15.28M*-$21.58M*$0.00*-$154.00K*$1.21M*$3.52M*-$1.73M*
2011-12-31-$2.21M*-$2.53M*$0.00*-$417.00K*$0.00*$1.25M*-$3.91M*
2011-09-30$2.70M*-$399.88M*-$267.00K*$450.73M*
2011-06-30-$18.26M$6.82M-$2.84M$11.82M*
2011-03-31$8.27M*-$11.50M*$2.76M*-$468.00K*
2010-12-31$12.90M*-$11.92M*$628.00K*$1.61M*

Similar stocks

Stock NameCountryMarket CapPE Ratio
RHYTHM PHARMACEUTICALS, INC. (RYTM)United States$6.771B-37.20
IONIS PHARMACEUTICALS INC (IONS)United States$7.277B-23.25
Liquidia Corp (LQDA)United States$6.347B51.23
Amneal Pharmaceuticals, Inc. (AMRX)$6.326B25.62
Spyre Therapeutics, Inc. (SYRE)United States$7.685B-43.69
Structure Therapeutics Inc. (GPCR)United States$7.710B-53.41
Praxis Precision Medicines, Inc. (PRAX)United States$7.884B-27.60
Mirum Pharmaceuticals, Inc. (MIRM)United States$5.798B-8.81
Travere Therapeutics, Inc. (TVTX)United States$5.712B-123.10
Oruka Therapeutics, Inc. (ORKA)United States$5.663B-43.76